Alma Gregory Sorensen, RadNet, Inc.'s Chief Strategy Officer, executed the sale of 15,000 shares of common stock on March 18, 2026, cumulatively valued at approximately $932,280. The disposition was carried out in two separate trades recorded the same day.
In the larger of the two transactions Sorensen sold 14,200 shares at an average price of $62.12 per share, with the individual trade prices spanning from $61.65 to $62.65. The smaller transaction comprised 800 shares sold at an average of $62.72, with transactional prices ranging from $62.67 to $63.67.
Two days earlier, on March 16, Sorensen also sold 5,919 shares of RadNet common stock at a price of $61.72 per share, an amount valued at $365,320. Following the March 16 and March 18 transactions combined, Sorensen directly holds 1,223,923 shares of RadNet.
RadNet's shares are trading near the levels recorded in these sales; the stock is quoted at $62.02, close to the average prices reported in the March trades. Separately, InvestingPro analysis referenced in company commentary suggests the stock may be overvalued at current price levels.
On a company-wide basis, RadNet carries a market capitalization of $4.8 billion and reported revenue growth of 11.5%. Analysts covering the company project RadNet will return to profitability in the current year with forecasted earnings of $0.69 per share, following a loss reported over the last twelve months.
Investor sentiment on Wall Street remains positive, with analyst price targets spanning $86 to $100 per share, implying material upside from current prices. Those projections sit alongside the company’s recently reported fourth-quarter 2025 financials, which showed an earnings per share result of $0.23, a beat of analysts’ expectations by 14.03%. Revenue for the quarter totaled $547.7 million, outperforming consensus estimates by 6.03%.
Jefferies has reiterated a Buy rating on RadNet and maintained a price target of $91.00. In its commentary, Jefferies noted that RadNet’s guidance for fiscal 2026 is in line with market expectations and emphasized continued strength in the outpatient imaging segment. The firm also highlighted the company’s ability to sustain double-digit EBITDA growth despite recent operational challenges.
The transactions by the company’s Chief Strategy Officer, coupled with RadNet’s recent quarter that exceeded expectations and positive analyst coverage, provide investors multiple data points to weigh when assessing the stock near its current trading levels.